NIH-funded research NIH-funded research

Prenatal alcohol exposure and fetal development mechanisms

Official title: Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD)

Funded at North Carolina Central University · NIH-11416833 · Data updated 2026-11-12

Researchers are studying how alcohol exposure before birth causes limb and brain defects, using zebrafish and mouse models to find new pathways and potential treatments that could reduce FASD.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorth Carolina Central University
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 20, 2022
Project endAugust 31, 2027
Funding year2026
Award (this year)$198,977
NIH project number5U54AA030451-05
Project IDNIH-11416833 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with or at risk for FASD or their families, including patients interested in future therapeutic avenues or participating in related studies.

Less likely to help

Some patients may not directly benefit if findings do not translate to clinical therapies or if ethanol exposure occurs outside studied windows.

What this research studies

This project uses zebrafish and mice to identify genes and chemical compounds that influence how alcohol affects developing limbs and organs. It combines genetic knockout approaches with high-throughput screening of chemical libraries to pinpoint factors that rescue or worsen ethanol-induced defects. By focusing on the sonic hedgehog signaling pathway and related gene sets, the study aims to uncover mechanisms that could inform future prevention or intervention strategies for FASD. The work integrates cell systems with whole-animal models to translate basic findings into clinically meaningful insights.

Why it matters

Potential benefit: If successful, the research could lead to new targets or compounds that reduce the severity of FASD in humans.

How similar studies have gone: Previous work shows that Shh signaling and related pathways are linked to ethanol teratogenesis and that animal models can reveal modifier genes.

Where this research is happening

  • North Carolina Central University
    Durham, United States
    Active

Researchers

  • Principal investigator: Williams, Kevin Peter — North Carolina Central University
  • Study coordinator: Williams, Kevin Peter

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.